(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue of the Journal of the ...
Sep 20, 2012
0
0
Most patients have positive views about the ability of artificial intelligence (AI) to improve care but have concerns about unintended consequences, according to a research letter published online May 4 in JAMA Network Open.
May 13, 2022
0
2
(HealthDay) -- The association between vascular disease, as measured by abdominal aortic calcifications (AACs), and disc height loss is independent of cardiovascular disease and is largely explained by patient age, gender, ...
Jun 8, 2012
0
0
(HealthDay)—Childhood vaccination with the bacille Calmette-Guérin (BCG) vaccine is associated with a reduced risk for lung cancer, according to a study published online Sept. 25 in JAMA Network Open.
Nov 18, 2019
0
13
(HealthDay)—Smoking is tied to significantly shorter disease-free survival (DFS) and time to recurrence (TTR) in patients undergoing treatment for stage III colon cancer, according to a study published April 1 in the Journal ...
Apr 6, 2013
2
0
Tezepelumab is associated with a reduction in occlusive mucus plugs versus placebo in adults with uncontrolled asthma, according to a study published in the October issue of NEJM Evidence.
Sep 29, 2023
0
1
(HealthDay)—For HIV-infected individuals with recurrent Clostridium difficile infection, fecal microbiota therapy is feasible, according to a letter published in the May 21 issue of the Annals of Internal Medicine.
May 22, 2013
0
0
(HealthDay)—For patients with osteoarthritis (OA) of the knee or hip, tanezumab is associated with significant improvements in pain and physical function versus placebo, according to a study published in the July 2 issue ...
Jul 3, 2019
0
1
(HealthDay) -- Patients with atrial fibrillation who have chronic kidney disease are at higher risk of stroke or systemic thromboembolism and bleeding, according to a study published in the Aug. 16 issue of the New England ...
Aug 16, 2012
0
0
(HealthDay)—Standardized screening for autism spectrum disorder (ASD) is recommended at ages 18 and 24 months in primary care, according to a clinical report published online Dec. 16 in Pediatrics.
Dec 23, 2019
0
3
